Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

HypErthermia as an Additional Treatment for the Biology and Experience of Depression

NCT: NCT05041361 · COMPLETED

NCT IDNCT05041361
StatusCOMPLETED
Start Date2021-10-11
Completion2023-03-01
SponsorUniversity of California, San Francisco (OTHER)
First posted
Last updated

Brief Summary

This single-arm feasibility trial administered up to 8 weekly (early phase) or 4 bi-weekly (later phase) whole-body hyperthermia (WBH) sessions and 8 weekly cognitive behavioral therapy (CBT) sessions to adults aged 18 years or older with major depressive disorder (MDD).

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑